Table 3. Variables associated with all-cause mortality or infection-related readmission within 90-days of index infection, n = 20.
| Characteristic | Unadjusted OR (95% CI) |
P-value | Adjusted OR (95% CI) |
P-value |
|---|---|---|---|---|
| Receipt of IE combination therapy | 14.6 (1.7–128.4) | 0.004 | Not Tested | -- |
| Congestive heart failure | 4.5 (0.8–25.6) | 0.18 | Not Tested | -- |
| Receipt of fluoroquinolone-based IE combination therapy | 4.2 (1.1–15.7) | 0.03 | 6.7 (1.4–30.4) | 0.02 |
| Septic shock | 3.4 (0.97–12.1) | 0.05 | 5.2 (1.1–23.2) | 0.03 |
| Pseudomonas aeruginosa IE | 2.6 (0.6–10.2) | 0.17 | Not Tested | -- |
| Prior healthcare exposure, 180 days | 0.35 (0.1–1.2) | 0.13 | Not Tested | -- |
| Indwelling device on admission | 0.33 (0.07–1.5) | 0.18 | Not Tested | -- |
| IE surgery | 0.4 (0.1–1.9) | 0.31 | Not Tested | -- |
| Left-sided IE | 0.4 (0.1–1.6) | 0.21 | Not Tested | -- |
Abbreviations: IE, infective endocarditis